# OnCo record nct07288112 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07288112/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07288112", "NCT07288112" ;
  schema:name "DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma"@en ;
  schema:description "A phase 1/2 trial of DOC1021 in melanoma, run by Diakonos Oncology Corporation, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07288112/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07288112> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-04-06" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/doc1021/> ;
  onco:companies <https://onco.cc/companies/diakonos-oncology/> .